NO20052480L - Farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer. - Google Patents
Farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer.Info
- Publication number
- NO20052480L NO20052480L NO20052480A NO20052480A NO20052480L NO 20052480 L NO20052480 L NO 20052480L NO 20052480 A NO20052480 A NO 20052480A NO 20052480 A NO20052480 A NO 20052480A NO 20052480 L NO20052480 L NO 20052480L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical compositions
- treating agent
- controlled release
- release pharmaceutical
- charged polymers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/278,912 US20030114394A1 (en) | 2001-10-29 | 2002-10-24 | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
US43850103P | 2003-01-08 | 2003-01-08 | |
PCT/EP2003/004316 WO2004037229A1 (en) | 2002-10-24 | 2003-04-25 | Extended, controlled release pharmaceutical compositions comprising charged polymers |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052480D0 NO20052480D0 (no) | 2005-05-23 |
NO20052480L true NO20052480L (no) | 2005-07-25 |
Family
ID=32179474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052480A NO20052480L (no) | 2002-10-24 | 2005-05-23 | Farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1556015B1 (pl) |
JP (1) | JP5204374B2 (pl) |
KR (1) | KR20050083802A (pl) |
CN (2) | CN101327326A (pl) |
AR (1) | AR039464A1 (pl) |
AU (1) | AU2003233066B2 (pl) |
BR (1) | BR0315576A (pl) |
CA (1) | CA2503383C (pl) |
CO (1) | CO5700711A2 (pl) |
ES (1) | ES2618300T3 (pl) |
HR (1) | HRP20050448A2 (pl) |
MA (1) | MA27493A1 (pl) |
ME (2) | MEP34108A (pl) |
MX (1) | MXPA05004330A (pl) |
NO (1) | NO20052480L (pl) |
NZ (1) | NZ539512A (pl) |
PE (2) | PE20040323A1 (pl) |
PL (1) | PL376537A1 (pl) |
RS (1) | RS20050321A (pl) |
RU (2) | RU2366410C2 (pl) |
TW (1) | TW200406223A (pl) |
WO (1) | WO2004037229A1 (pl) |
ZA (1) | ZA200503133B (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2607626A1 (en) * | 2005-05-10 | 2006-11-16 | Novartis Ag | Modified release famciclovir pharmaceutical compositions |
WO2017130208A1 (en) * | 2016-01-29 | 2017-08-03 | Faheem Hyder Pottoo | Triple drug combination for treatment of status epilepticus and/or partial seizures and/or partial seizures with associated neurological disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE151286T1 (de) * | 1983-11-14 | 1997-04-15 | Columbia Lab Inc | Bioadhäsive mittel |
US5578315A (en) * | 1993-12-01 | 1996-11-26 | Rutgers, The State University Of New Jersey | Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US6197327B1 (en) * | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
US6624200B2 (en) * | 1998-08-25 | 2003-09-23 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
DE69819748T2 (de) * | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
US6248358B1 (en) * | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
UA74168C2 (uk) * | 1999-10-05 | 2005-11-15 | Коламбіа Леборетеріс (Бермуда) Лімітед | Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу |
-
2002
- 2002-10-28 CN CNA2008100962684A patent/CN101327326A/zh active Pending
-
2003
- 2003-04-24 TW TW092109642A patent/TW200406223A/zh unknown
- 2003-04-25 PE PE2003000414A patent/PE20040323A1/es not_active Application Discontinuation
- 2003-04-25 BR BR0315576-5A patent/BR0315576A/pt not_active Application Discontinuation
- 2003-04-25 RS YUP-2005/0321A patent/RS20050321A/sr unknown
- 2003-04-25 PL PL376537A patent/PL376537A1/pl not_active Application Discontinuation
- 2003-04-25 NZ NZ539512A patent/NZ539512A/en not_active IP Right Cessation
- 2003-04-25 PE PE2008001302A patent/PE20081613A1/es not_active Application Discontinuation
- 2003-04-25 KR KR1020057006990A patent/KR20050083802A/ko not_active Application Discontinuation
- 2003-04-25 CN CN038254182A patent/CN1703205B/zh not_active Expired - Fee Related
- 2003-04-25 CA CA2503383A patent/CA2503383C/en not_active Expired - Fee Related
- 2003-04-25 WO PCT/EP2003/004316 patent/WO2004037229A1/en active Application Filing
- 2003-04-25 MX MXPA05004330A patent/MXPA05004330A/es active IP Right Grant
- 2003-04-25 AU AU2003233066A patent/AU2003233066B2/en not_active Ceased
- 2003-04-25 ES ES03727364.6T patent/ES2618300T3/es not_active Expired - Lifetime
- 2003-04-25 EP EP03727364.6A patent/EP1556015B1/en not_active Expired - Lifetime
- 2003-04-25 ME MEP-341/08A patent/MEP34108A/xx unknown
- 2003-04-25 RU RU2005115574/15A patent/RU2366410C2/ru not_active IP Right Cessation
- 2003-04-25 JP JP2005501510A patent/JP5204374B2/ja not_active Expired - Fee Related
- 2003-04-25 ME MEP-2008-341A patent/ME00233B/me unknown
- 2003-04-28 AR ARP030101458A patent/AR039464A1/es not_active Application Discontinuation
-
2005
- 2005-04-19 ZA ZA200503133A patent/ZA200503133B/en unknown
- 2005-05-17 CO CO05047639A patent/CO5700711A2/es not_active Application Discontinuation
- 2005-05-19 HR HR20050448A patent/HRP20050448A2/hr not_active Application Discontinuation
- 2005-05-20 MA MA28292A patent/MA27493A1/fr unknown
- 2005-05-23 NO NO20052480A patent/NO20052480L/no not_active Application Discontinuation
-
2009
- 2009-04-01 RU RU2009112072/15A patent/RU2009112072A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO5700711A2 (es) | 2006-11-30 |
AU2003233066B2 (en) | 2009-11-19 |
HRP20050448A2 (en) | 2005-12-31 |
RU2009112072A (ru) | 2010-10-10 |
PE20081613A1 (es) | 2008-11-15 |
ME00233B (me) | 2011-05-10 |
NO20052480D0 (no) | 2005-05-23 |
CN1703205A (zh) | 2005-11-30 |
JP5204374B2 (ja) | 2013-06-05 |
AU2003233066A1 (en) | 2004-05-13 |
TW200406223A (en) | 2004-05-01 |
RU2005115574A (ru) | 2005-10-27 |
WO2004037229A1 (en) | 2004-05-06 |
MXPA05004330A (es) | 2005-08-02 |
JP2006506453A (ja) | 2006-02-23 |
CN1703205B (zh) | 2010-12-01 |
ZA200503133B (en) | 2006-12-27 |
MA27493A1 (fr) | 2005-08-01 |
EP1556015B1 (en) | 2017-02-22 |
AR039464A1 (es) | 2005-02-23 |
RS20050321A (en) | 2007-08-03 |
CA2503383A1 (en) | 2004-05-06 |
PE20040323A1 (es) | 2004-06-10 |
BR0315576A (pt) | 2005-08-30 |
ES2618300T3 (es) | 2017-06-21 |
CN101327326A (zh) | 2008-12-24 |
NZ539512A (en) | 2009-03-31 |
PL376537A1 (pl) | 2006-01-09 |
CA2503383C (en) | 2013-03-12 |
EP1556015A1 (en) | 2005-07-27 |
MEP34108A (en) | 2011-02-10 |
RU2366410C2 (ru) | 2009-09-10 |
KR20050083802A (ko) | 2005-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008021113A3 (en) | Transdermal methods and systems for treating alzheimer's disease | |
ATE288256T1 (de) | Dermale zusammensetzungen | |
NO982764L (no) | Oppfinnelse og anordning for transdermal anordning for avgivelse av flurbiprofen | |
BRPI0416032A (pt) | excipientes em veìculos de distribuição de fármacos | |
GB2430367B (en) | Ion binding polymers and uses thereof | |
NO20053545L (no) | Bindingsmidler som inhiberer myostatin. | |
NZ600257A (en) | Device and method for delivery of two or more drug agents | |
CL2003002277A1 (es) | Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente. | |
BRPI0516718B8 (pt) | formulação de liberação modificada de ibuprofeno fornecendo liberação imediata e prolongada do fármaco | |
DE60331552D1 (de) | Darreichungssysteme von wirkstoffen mit poly(ethylene-co(meth)akrylate, medizinische vorrichtung und verfahren | |
TNSN08365A1 (en) | Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer | |
NO20023473D0 (no) | Sammensetninger for levering av en kortisol antagonist | |
MX2009003516A (es) | Formas de dosificacion solidas farmaceuticas que comprenden compuestos microincluidos en polimeros ionicos insolubles en agua. | |
MX2012002727A (es) | Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo. | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
NO20052480L (no) | Farmasoytiske sammensetninger med kontrollert frigjoring omfattende ladede polymerer. | |
PL1796725T3 (pl) | Leczenie lub profilaktyka krwawień nieplanowych u kobiet przyjmujących lek zawierający progestogen | |
FR2889062B1 (fr) | Composition cosmetique comprenant un copolymere ampholyte | |
BR112022019846A2 (pt) | Método de tratamento de esclerose múltipla recorrente (rms), métodos para reduzir a taxa de recorrência anualizada (arr), reduzir o risco de experimentar ccdp12 e aumentar o tempo até o início de ccdp12 e compostos | |
BRPI0415725A (pt) | formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa | |
AU2003256882A1 (en) | Methods of drug delivery using sulphated chitinous polymers | |
HK1109338A1 (en) | Ion binding polymers and uses thereof | |
NO20072851L (no) | Hoydose forlenget frigivelses formulering av gepiron | |
NO20065653L (no) | Fremgangsmate for a behandle sykdommer med vilkarlige sampolymerer | |
TW200640461A (en) | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |